OpenAlex
PricingAboutJobs
Log inGet started
Work

Ibrutinib: First Global Approval

HTML

Year: 2014
Type: review
Source: Drugs
DOI: 10.1007/s40265-014-0178-8
Authors: Fiona Cameron, Mark Sanford
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: ibrutinib, BTK inhibitors, mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, diffuse large B-cell lymphoma, multiple myeloma, follicular lymphoma, Waldenström macroglobulinemia, breakthrough therapy designation, regulatory approval, drug development milestones
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2107307057
FWCI: 2.69
Cites: 24
Cited by: 175
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms